Hadassah Inoculates First Patient in Trial of Israeli-Made COVID-19 Vaccine

Tuesday, Nov 3 2020

Anar Ottolenghi, a 34-year-old doctoral student in immunology, was one of the first Israelis to be inoculated on Sunday morning as part of the Phase I clinical trial of an Israeli-made coronavirus vaccine at Hadassah Hospital Ein Kerem.

“I feel good, excited,” Ottolenghi said. “I want to encourage as many people as possible to join the experiment and help the entire public.”

The Israeli vaccine, known as “Brilife,” was developed by the Israel Institute for Biological Research (IIBR), and Sunday marked the launch of its Phase I clinical trial, in which 80 healthy volunteers between the ages of 18 and 55 will participate—40 at Hadassah and 40 at Sheba Medical Center in Tel Hashomer. Each volunteer will receive an injection, with some receiving the vaccine and some receiving a placebo.

Volunteers will be monitored over the course of three weeks to assess the vaccine’s safety. Researchers will also examine whether volunteers develop antibodies to the coronavirus. If Phase I yields successful results, Phase II will probably begin in December with 960 healthy volunteers at medical centers throughout the country. Phase II will continue to monitor the vaccine’s safety and gauge effectiveness and also pinpoint appropriate doses. If the first two phases are successful, a Phase III trial/p of 30,000 volunteers will begin in April or May.

Prof. Shmuel Shapira, head of IIBR and former deputy director general of Hadassah Ein Kerem, noted, “IIBR has developed many vaccines.” He continued, “Six years before this crisis, we had already started preparing for such an event.”

Prime Minister Benjamin Netanyahu commented, “The true exit from the coronavirus crisis is in the development of vaccines. With God’s help, we will have a vaccine made here in Israel.”

Read the full story in The Jerusalem Post.


Hadassah Ein Kerem just reported that two more Israelis were vaccinated at the hospital on Monday, November 2, 2020: Jerusalemite Effi, age 26, a computer scientist originally from England, and Eli Ein-Dor, age 50, a programmer with the Israeli Port Authority.

“I am neither a doctor nor a nurse, so in my eyes, the best way to contribute is by participating in the trial,” Effi said.  Read more about Effi

Sunday,  November 8, 2020 Update:
Four women receive Brilife COVID vaccination, as Hadassah trials continue


Learn more about the Hadassah Medical Organization.

Related Stories


Tuesday, Jan 12 2021

Hadassah Speedily Vaccinates Its Staff Against COVID-19

As of January 11, out of the 6,500 individuals who work at the Hadassah Medical Organization, 4,800 had received their first dose of the Pfizer vaccine, and 1,000 had received the second dose.


Tuesday, Jan 5 2021

Mary, From Bethlehem, Experiences Personal Christmas Miracle at Hadassah

Christmas Eve is always a special time for Mary A, an 86-year-old resident of Bethlehem.


Tuesday, Dec 29 2020

Nurses Inject Hope at Hadassah Hospital Ein Kerem

The sun has just come up. It is 6 am and 18 pairs of eyes are staring at two Hadassah Hospital Ein Kerem nurses. One nurse is seated and the other is standing over her, a needle in hand.


Monday, Dec 21 2020

Hadassah Collaborates to Develop a Face Mask that Kills the Coronavirus

The Hadassah Medical Organization, the Israel Institute for Biological Research (IIBR) and Tera Novel, an Israeli start-up company, have collaboratively developed an innovative antiviral and antibacterial mask...


Donation Questions


(800) 928-0685

Membership Questions


(800) 664-5646

Israel Travel


(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

More ›

Show More